New Products from BBI to be Showcased at MEDICA 2012

We are pleased to announce that BBInternational, BBI Enzymes and SCIPAC will be exhibiting together at this year’s Medica Exhibition, taking place from the 14th to the 17th November in Düsseldorf, Germany. We will be showcasing a selection of new products including the Novarum smartphone reader and our novel integrated blood sample collection technology; AtomoRapid.

The latest products include:

Monoclonal antibodies
Our antibody range is focused on high quality, best in class antibodies which have been proven to perform well in a number of applications including Western Blot, ELISA and Lateral Flow. We offer over 1000 clones to over 75 different markers.

GoldLink rapid conjugation kits
If your focus is Lateral flow, our GoldLink kits allow users to select and screen multiple antibodies in-house; saving money on externally sourced custom development projects, with finished gold antibody conjugate available in just 15 minutes.

FAD Dependent Glucose Dehydrogenase
BBI will be launching a FAD dependent Glucose Dehydrogenase to complement our existing market leading range of Glucose Oxidase enzymes for blood glucose monitoring.

See the Novarum Smartphone Reader live in action!
One of the first mobile readers available for the IVD market, the Novarum smartphone reader uses smartphone based software which can be developed to read any lateral flow test. Witness first-hand how the portable technology allows users to test in any location - providing instant access to quantified results, saving time and cost over lab based testing.

AtomoRapid integrated blood sample collection capabilities
BBI are adding integrated sample collection capabilities to their lateral flow development service. We will now be offering the world’s first hand held integrated rapid diagnostic device. This novel lateral flow platform, which has won engineering excellence award in Australia, runs the complete test in a single device making it ideal for clinicians to use away from the laboratory as well as enabling individuals to conduct their own blood tests at home.